We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eli Lilly And Co | LSE:0Q1G | London | Ordinary Share | ELI LILLY ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 81.83 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 212 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 34.12B | 5.24B | 5.5202 | 139.49 | 730.97B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/5/2024 | 21:07 | ALNC |  Eli Lilly reaches settlement with Totality Medispa |
| 30/4/2024 | 13:26 | ALNC | TOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demand |
| 08/3/2024 | 15:16 | ALNC | Eli Lilly's Donanemab Alzheimer's drug hit by delays |
| 06/2/2024 | 12:44 | ALNC | TOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug craze |
| 26/1/2024 | 06:04 | ALNC | Eli Lilly weight loss drug could be supplied to UK 'in weeks' |
| 23/1/2024 | 18:48 | ALNC | IN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapy |
| 17/11/2023 | 14:18 | ALNC | TOP NEWS: Eli Lilly to invest USD2.5 billion in Germany |
| 09/11/2023 | 06:09 | ALNC | Eli Lilly diabetes drug authorised for weight management, loss in UK |
| 08/11/2023 | 20:15 | ALNC | US approves highly anticipated Eli Lilly weight loss drug |
| 02/11/2023 | 11:42 | ALNC | TOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costs |
1 Year Eli Lilly Chart |
Intraday Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
